RFDA - ETF AI Analysis
Top Page
RiverFront Dynamic US Dividend Advantage ETF (RFDA)
RFDA, the RiverFront Dynamic US Dividend Advantage ETF, earns a solid overall rating driven largely by strong, diversified holdings like Microsoft, Johnson & Johnson, Nvidia, and ConocoPhillips, all supported by healthy financial performance and long-term growth themes in areas such as cloud, AI, healthcare, and energy. The fund’s score is held back somewhat by positions like Citigroup and Hewlett Packard Enterprise, where profitability, valuation, and technical concerns introduce more uncertainty. A key risk factor is the exposure to individual companies with high valuations or sector-specific challenges, which could increase volatility even within this diversified dividend-focused portfolio.
RFDA vs. SPDR S&P 500 ETF (SPY)
- AUM
- 78.14M
- Region
- North America
- Expense Ratio
- 0.52%
- Beta
- 0.80
- Issuer
- ALPS
- Inception Date
- Jun 06, 2016
- Dividend Yield
- 1.98%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
RFDA Summary
The RiverFront Dynamic US Dividend Advantage ETF (RFDA) invests in a wide range of U.S. companies and focuses on stocks that pay dividends. It doesn’t track a fixed index, but instead follows a total U.S. market theme and adjusts its holdings over time. The fund owns well-known names like Microsoft and Johnson & Johnson, along with many others across sectors such as financials, health care, energy, and technology. Someone might invest for a mix of growth and regular dividend income, plus broad diversification. A key risk is that the value can rise or fall with the overall stock market.
How much will it cost me?
This ETF has an expense ratio of 0.52%, which means you’ll pay about $5.20 per year for every $1,000 invested. That’s higher than the average low-cost index ETF because this fund is actively managed and uses a dynamic strategy rather than simply tracking a market index.
What would affect this ETF?
RFDA could benefit from a strong U.S. economy, stable or falling interest rates, and continued growth in sectors like technology, health care, and energy, which support both stock prices and dividend payments from top holdings such as Nvidia, Microsoft, and Johnson & Johnson. On the downside, rising interest rates, financial sector stress, weaker energy prices, or tighter regulations on banks and large tech firms could pressure dividends and share prices across its broad U.S. market exposure.
RFDA Top 10 Holdings
RFDA leans into a mix of dependable dividend payers and a few growth engines, with all its bets placed in U.S. stocks. Nvidia and Microsoft give the fund a tech-powered boost, with Nvidia steadily rising and Microsoft showing strong recent momentum. On the defensive side, Johnson & Johnson and Merck are quietly supporting performance with steady gains. Energy names like Phillips 66 have been a surprising tailwind, while big banks such as JPMorgan and Citigroup have been more mixed, occasionally dragging on returns. Overall, the fund tilts toward financials, tech, health care, and energy for income and growth.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 JNJ | Johnson & Johnson | 3.22% | $2.53M | $646.92B | 41.21% | 78Outperform |
 NVDA | Nvidia | 3.19% | $2.51M | $5.25T | 13.81% | 76Outperform |
 UNH | UnitedHealth | 2.96% | $2.33M | $368.36B | 12.13% | 72Outperform |
 JPM | JPMorgan Chase | 2.91% | $2.29M | $892.59B | 10.40% | 72Outperform |
 COP | Conocophillips | 2.79% | $2.19M | $177.75B | 66.83% | 78Outperform |
 PSX | Phillips 66 | 2.59% | $2.04M | $107.15B | 98.29% | 73Outperform |
 MSFT | Microsoft | 2.69% | $2.11M | $3.95T | -0.04% | 79Outperform |
 KO | Coca-Cola | 2.62% | $2.06M | $392.31B | 30.15% | 75Outperform |
 C | Citigroup | 2.40% | $1.88M | $205.80B | 21.49% | 68Neutral |
 XOM | Exxon Mobil | 2.20% | $1.72M | $739.77B | 55.18% | 74Outperform |
RFDA Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For RFDA, the sentiment is Positive. The current price of 73.04 is above the 20-day moving average (MA) of 71.92, above the 50-day MA of 72.43, and above the 200-day MA of 68.18, indicating a bullish trend. The MACD of 0.26 indicates Negative momentum. The RSI at 61.25 is Neutral, neither overbought nor oversold. The STOCH value of 84.31 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for RFDA.
RFDA Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| RFDA | $73.04 | $79.00(8.16% Upside) | $78.14M | 0.52% | 69Neutral |
 BAMD | $34.18 | $38.22(11.80% Upside) | $100.25M | 0.87% | 70Outperform |
 STNC | $36.91 | $42.51(15.18% Upside) | $92.30M | 0.85% | 68Neutral |
 SOVF | $31.96 | $37.58(17.59% Upside) | $91.03M | 0.75% | 70Neutral |
 PFOE | $22.21 | $28.85(29.86% Upside) | $88.59M | 0.59% | 75Outperform |
 VAMO | $36.07 | $42.11(16.73% Upside) | $87.83M | 0.65% | 63Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| RFDA | RiverFront Dynamic US Dividend Advantage ETF | 73.04 | 10.55 | 16.89% | |
| BAMD | Brookstone Dividend Stock ETF | 34.18 | 4.79 | 16.29% | |
| STNC | Stance Equity ESG Large Cap Core ETF | 36.91 | 3.93 | 11.92% | |
| SOVF | Sovereign's Capital Flourish Fund | 31.96 | 2.92 | 10.05% | |
| PFOE | Pathfinder Focused Opportunities ETF | 22.21 | -2.64 | -10.63% | |
| VAMO | Cambria Value & Momentum ETF | 36.07 | 3.50 | 10.75% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.